A detailed history of Walker Asset Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Walker Asset Management, LLC holds 4,411 shares of GILD stock, worth $414,413. This represents 0.25% of its overall portfolio holdings.

Number of Shares
4,411
Previous 4,391 0.46%
Holding current value
$414,413
Previous $301,000 22.59%
% of portfolio
0.25%
Previous 0.22%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$66.59 - $83.99 $1,331 - $1,679
20 Added 0.46%
4,411 $369,000
Q2 2024

Jul 12, 2024

SELL
$63.15 - $72.88 $23,491 - $27,111
-372 Reduced 7.81%
4,391 $301,000
Q1 2024

Apr 10, 2024

BUY
$71.58 - $87.29 $11,810 - $14,402
165 Added 3.59%
4,763 $348,000
Q4 2023

Jan 08, 2024

BUY
$73.27 - $83.09 $61,839 - $70,127
844 Added 22.48%
4,598 $372,000
Q3 2023

Oct 27, 2023

BUY
$73.94 - $80.67 $961 - $1,048
13 Added 0.35%
3,754 $281,000
Q2 2023

Jul 13, 2023

BUY
$76.01 - $86.7 $2,508 - $2,861
33 Added 0.89%
3,741 $288,000
Q1 2023

Apr 11, 2023

BUY
$77.31 - $88.08 $2,319 - $2,642
30 Added 0.82%
3,708 $307,000
Q4 2022

Feb 01, 2023

BUY
$62.32 - $89.47 $17,948 - $25,767
288 Added 8.5%
3,678 $315,000
Q3 2022

Oct 11, 2022

BUY
$59.54 - $68.01 $2,679 - $3,060
45 Added 1.35%
3,390 $209,000
Q2 2022

Jul 29, 2022

SELL
$57.72 - $65.01 $11.6 Million - $13 Million
-200,532 Reduced 98.36%
3,345 $207,000
Q2 2022

Jul 25, 2022

BUY
$57.72 - $65.01 $11.8 Million - $13.3 Million
203,877 New
203,877 $12.6 Million
Q1 2022

Apr 13, 2022

SELL
$57.92 - $72.58 $185,459 - $232,401
-3,202 Closed
0 $0
Q4 2021

Apr 14, 2022

BUY
$64.88 - $73.64 $207,745 - $235,795
3,202 New
3,202 $232,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Walker Asset Management, LLC Portfolio

Follow Walker Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walker Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walker Asset Management, LLC with notifications on news.